Despite state bans, abortions have almost doubled. The reason? Pills via telehealth

Despite State Bans, Abortions Have Nearly Doubled: Pills via Telehealth Drive the Trend

Despite state bans abortions have almost - Despite state bans abortions have nearly doubled since 2021, driven by the rise of medication abortion through telehealth services. Following the Supreme Court's Dobbs decision, which overturned Roe v. Wade in 2022, access to abortion care has become a contentious issue across the U.S. However, the availability of abortion pills via remote prescriptions has allowed many patients to bypass restrictive laws. Recent data reveals that the total number of abortions has nearly doubled, with medication abortions via telehealth playing a pivotal role in this surge.

Adapting to Legal Restrictions

Reproductive health advocates have been working tirelessly to maintain access despite escalating legal hurdles. Organizations such as the Massachusetts Medication Abortion Access Project have adapted by mailing pills to over 3,500 patients monthly, even in states where abortion bans have been enforced. When a federal appeals court ruling in May blocked mifepristone shipments, experts like Foster outlined alternative strategies for patients, including using misoprostol or waiting for legal changes.

Although mifepristone and misoprostol together form the most effective medication abortion method, their use has become a key focus for opponents. Misoprostol, while FDA-approved for treating ulcers, is also used off-label to manage miscarriages and induce labor. Foster emphasized that misoprostol is less effective for abortions and causes more side effects, yet patients continue to prioritize speed and accessibility over complications.

Two Major Shifts in Abortion Access

The post-Dobbs era has seen two critical developments shaping abortion availability. First, the number of abortions in 2025 reached nearly double the 2021 total, according to the Society of Family Planning's #WeCount report. By December 2025, 29% of all abortions were conducted via telehealth, highlighting the adaptability of patients and providers. Second, the reliance on medication pills has created a challenge for opponents seeking to restrict access entirely.

States with abortion bans are locked in legal battles over pill distribution. Louisiana's recent lawsuit temporarily halted mifepristone shipments, but the U.S. Supreme Court restored access while lower courts deliberated. Meanwhile, advocates push for the Trump administration to limit pill availability through FDA reviews or stricter regulations. Despite these efforts, telehealth providers remain undeterred, emphasizing the resilience of patients in securing care.

Resilience and Strategic Workarounds

Despite restrictions, telehealth groups report that patients are increasingly confident in their ability to access abortion pills. Elisa Wells of Plan C described the trend as irreversible, noting that once people learn about the convenience of mail-order abortions, they are unlikely to abandon it. This shift has created a new normal in reproductive healthcare, with pills becoming a lifeline for those in restrictive states.

Organizations have also prepared for the worst-case scenario. If mifepristone is banned, they plan to rely on misoprostol, which is FDA-approved for ulcers and commonly used off-label. David Cohen, a Drexel University law professor, argued that banning misoprostol would require proving it's unsafe for its primary use—a challenge that remains unmet. Companies like Carafem have already tested this alternative, transitioning to misoprostol-only methods during previous restrictions.

Global Supply Chains as a Solution

To ensure continued access, telehealth providers are turning to international sources. Networks like Aid Access and online pharmacies in India have become critical in bypassing domestic restrictions. This strategy guarantees that patients can still obtain abortion pills even if state-level bans tighten. The global reach of these supply chains underscores the importance of medication abortion in maintaining access despite legal obstacles.

Cohen highlighted the difficulty of enforcing the Comstock Act, a 1873 law targeting the mailing of abortion-related materials. While the act could be revived, its effectiveness in modern times is questionable. With the "War on Drugs" lasting decades, it's unlikely that abortion pill access would be completely halted. The combination of telehealth and international supply chains has created a robust system for patients seeking care, despite the ongoing political battles.